ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2015

Abstract Number: 215

Calcium Hydroxyapatite Crystals Inhibit Interleukin-6- and Interferon-γ –Induced Anti-Osteoclastogenic Signaling in Human Osteoclast Precursors

Geraldine M. McCarthy1, Clare C. Cunningham2, Emma M. Corr3 and Aisling Dunne3, 1University College Dublin, Dublin, Ireland, 2School of Biochemistry and Immunology, Trinity College Dublin, Dubln, Ireland, 3School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2015

Date of first publication: September 29, 2015

Keywords: Crystal-induced arthritis, Osteoarthritis, osteoclastogenesis and signal transduction, RANK/RANKL pathway

Session Information

Date: Sunday, November 8, 2015

Title: Metabolic and Crystal Arthropathies Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Intra-articular calcium hydroxyapatite (HA) crystals are present in the majority of osteoarthritic (OA) joints. They activate macrophages, synovial fibroblasts and articular chondrocytes, resulting in increased cell proliferation and the production of pro-inflammatory cytokines and matrix metalloproteases. This suggests a pathogenic role in OA by causing extracellular matrix degradation and subchondral bone remodeling. Total joint arthroplasty is performed when conservative therapies have proved unsuccessful in OA. However, particles generated from wear of prosthetic implants also induce pro-inflammatory cytokines, which drive osteoclastogenesis through up-regulation of receptor activator of nuclear factor kappa-B (RANK) ligand, an essential cytokine for the differentiation of osteoclasts. These bone-resorbing cells drive periprosthetic osteolysis through secretion of acid and the proteolytic enzyme cathepsin K and contribute to implant loosening. Both interleukin (IL)-6 and interferon (IFN)-γ exhibit anti-osteoclastogenic activity via activation of the JAK/STAT pathway. Titanium and bone cement wear particles can inhibit this effect, via activation of mitogen-activated protein kinases (MAPK) and induction of suppressor of cytokine signaling (SOCS) proteins. As synthetic HA is used as a biomimetic to coat orthopaedic implants, we sought to 1) determine whether HA crystals promote osteoclastogenesis, 2) determine whether HA crystals alter anti-osteoclastogenic signaling by IL-6 and IFN-γ and 3) elucidate the mechanism by which HA crystals may contribute to periprosthetic osteolysis.

Methods: Murine and human macrophages were stimulated with HA crystals for 3, 6 and 24 hours and expression of RANK ligand and cathepsin K was analysed by quantitative PCR. Human osteoclast precursors were stimulated with HA crystals and MAPK activation was detected by Western blot. Osteoclast precursors were treated with HA crystals for 1 hour prior to IL-6 or IFN-γ stimulation, and phosphorylation of signal transducer and activator of transcription (STAT) 1 and 3 was detected by Western blot. Up-regulation of (SOCS) 1 and 3 was analysed by q-PCR

Results: HA crystals (50μg/ml) up-regulate RANK ligand and cathepsin K in murine and human macrophages by 3 to 5-fold. Stimulation of human osteoclast precursors with HA induces the activation of p38, JNK and ERK MAPK. Pre-treatment of human osteoclast precursors with HA crystals inhibits both IFN-γ and IL-6-induced activation of STAT1 and STAT3 respectively (figs A and B). Furthermore, HA crystals up-regulate the expression of SOCS1 and SOCS3, an effect which is reduced by MAPK inhibition.

Conclusion: Based on these studies we propose that HA crystals could contribute 1) to periprosthetic osteolysis and 2) subchondral bone remodelling in OA through up-regulation of RANK ligand, and inhibition of the anti-osteoclastogenic activity of IL-6 and IFN-γ.

Description: Macintosh HD:Users:gmccarthy:Desktop:Slide 3.jpg


Disclosure: G. M. McCarthy, None; C. C. Cunningham, None; E. M. Corr, None; A. Dunne, None.

To cite this abstract in AMA style:

McCarthy GM, Cunningham CC, Corr EM, Dunne A. Calcium Hydroxyapatite Crystals Inhibit Interleukin-6- and Interferon-γ –Induced Anti-Osteoclastogenic Signaling in Human Osteoclast Precursors [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/calcium-hydroxyapatite-crystals-inhibit-interleukin-6-and-interferon-induced-anti-osteoclastogenic-signaling-in-human-osteoclast-precursors/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/calcium-hydroxyapatite-crystals-inhibit-interleukin-6-and-interferon-induced-anti-osteoclastogenic-signaling-in-human-osteoclast-precursors/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology